Cargando…

Future Considerations for the Evaluation of Hepatitis C Virus Treatments in Pan-Genotypic Therapy for Noncirrhotic Treatment-Naive Patients

Given the recent approval of the first pan-genotypic chronic hepatitis C virus (HCV) therapy, managed care, health systems, and clinicians will need to evaluate current practices related to essential laboratory assessments used to select therapy. Historically, clinicians and payers required a batter...

Descripción completa

Detalles Bibliográficos
Autores principales:	Calabrese, Martin J., Hynicka, Lauren M., de Bittner, Magaly Rodriguez, Shaya, Fadia T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Academy of Managed Care Pharmacy 2018
Materias:	Viewpoints
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10398219/ https://www.ncbi.nlm.nih.gov/pubmed/29290175 http://dx.doi.org/10.18553/jmcp.2018.24.1.20

Ejemplares similares

HIV Coinfection Predicts Failure of Ledipasvir/Sofosbuvir in Treatment-Naïve Noncirrhotic Patients With HCV Genotype 1
por: Berenguer, Juan, et al.
Publicado: (2019)

Serum soluble TWEAK levels are decreased in treatment naive noncirrhotic chronic hepatitis B patients
por: Asil, Mehmet, et al.
Publicado: (2016)

A Cost-Effectiveness Analysis of Shortened Direct-Acting Antiviral Treatment in Genotype 1 Noncirrhotic Treatment-Naive Patients With Chronic Hepatitis C Virus
por: Fawsitt, Christopher G., et al.
Publicado: (2019)

Cost-Effectiveness Analysis of Baseline Testing for Resistance-Associated Polymorphisms to Optimize Treatment Outcome in Genotype 1 Noncirrhotic Treatment-Naïve Patients With Chronic Hepatitis C Virus
por: Fawsitt, Christopher G., et al.
Publicado: (2020)

Eight-Week Outcomes of Ledipasvir/Sofosbuvir in Noncirrhotic Treatment-Naive Patients with Hepatitis C: Analysis of Pharmacy-Based Data
por: Andres, Jennifer, et al.
Publicado: (2018)

Mind the App: Considerations for the Future of Mobile Health in Canada
por: Zawati, Ma'n H, et al.
Publicado: (2019)

Ethical considerations for mandating food worker vaccination during outbreaks: an analysis of hepatitis A vaccine
por: Fleetwood, Janet
Publicado: (2021)

Treatment-shortening regimens for tuberculosis: updates and future priorities
por: Saluzzo, Francesca, et al.
Publicado: (2023)

Mobile Phones in Research and Treatment: Ethical Guidelines and Future Directions
por: Carter, Adrian, et al.
Publicado: (2015)

Immune Checkpoint Inhibitor Myocarditis Treatment Strategies and Future Directions
por: Moslehi, Javid, et al.
Publicado: (2022)

Targeting the Gut–Brain Axis with Fecal Microbiota Transplantation: Considerations on a Potential Novel Treatment for Parkinson's Disease
por: Contarino, Maria Fiorella, et al.
Publicado: (2022)

Multidisciplinary and Integrated Treatment for Substance Use Disorders and Hepatitis C in an Addiction Treatment Service in India
por: Ghosh, Abhishek, et al.
Publicado: (2022)

Opioid Use Disorder Education for Students and the Future of Opioid Overdose Treatment
por: Balapal, Neha, et al.
Publicado: (2022)

Comparison of prevention, screening and treatment of hepatitis C in Iran, Egypt and Georgia
por: Behzadifar, Masoud, et al.
Publicado: (2019)

Effectiveness of 8 or 12 Week Treatment Duration of Ledipasvir/Sofosbuvir for Hepatitis C: Evidence from a Large Academic Medical Center
por: Vega, Ana, et al.
Publicado: (2017)

Therapist-Supported Online Interventions for Children and Young People With Tic Disorders: Lessons Learned From a Randomized Controlled Trial and Considerations for Future Practice
por: Chamberlain, Liam R, et al.
Publicado: (2020)

Primary hepatic angiosarcoma with noncirrhotic portal hypertension: A case report
por: Wu, Xuwei, et al.
Publicado: (2023)

Considerations for Analyzing and Interpreting Data from Biometric Monitoring Technologies in Clinical Trials
por: Ratitch, Bohdana, et al.
Publicado: (2022)

Successful treatment of genotype 3 hepatitis C infection in a noncirrhotic HIV infected patient on chronic dialysis with the combination of sofosbuvir and velpatasvir: A case report
por: Begovac, Josip, et al.
Publicado: (2018)

Potential therapeutic options for coronavirus disease 2019: using knowledge of past outbreaks to guide future treatment
por: Lin, John, et al.
Publicado: (2020)

Nothing about us without us: considerations for ensuring rights‐affirming index case testing for young people
por: Parmley, Lauren E, et al.
Publicado: (2020)

Dengue Vaccine: Considerations before Rollout in Colombia
por: Villabona-Arenas, Christian Julian, et al.
Publicado: (2016)

Considerations on immunization anxiety-related reactions in clusters
por: Palacios, Ricardo
Publicado: (2014)

Considerations for Postacute Rehabilitation for Survivors of COVID-19
por: Sheehy, Lisa Mary
Publicado: (2020)

The antibiogram: key considerations for its development and utilization
por: Truong, William R, et al.
Publicado: (2021)

Corneal Refractive Surgery Considerations in Patients on Dupilumab
por: Moshirfar, Majid, et al.
Publicado: (2022)

The Late Arrival of Coronavirus Disease 2019 (COVID-19) in Africa: Mitigating Pan-continental Spread
por: Nachega, Jean, et al.
Publicado: (2020)

Solve-RD: systematic pan-European data sharing and collaborative analysis to solve rare diseases
por: Zurek, Birte, et al.
Publicado: (2021)

Telehealth Regulatory and Legal Considerations: Frequently Asked Questions
por: Cason, Jana, et al.
Publicado: (2011)

Considerations for the development of extreme heat policies in sport and exercise
por: Chalmers, Samuel, et al.
Publicado: (2020)

Considerations in boosting COVID-19 vaccine immune responses
por: Krause, Philip R, et al.
Publicado: (2021)

Considerations and concerns regarding the readiness to remove face coverings
por: Terada, Mari, et al.
Publicado: (2022)

Stunting: methodological considerations for improved study design and reporting
por: Rohloff, Peter, et al.
Publicado: (2023)

Ethical Considerations of Unsolicited Medical Opinion in Movement Disorders
por: Araújo, Rui, et al.
Publicado: (2023)

Ethical Considerations of Using ChatGPT in Health Care
por: Wang, Changyu, et al.
Publicado: (2023)

A Call for Biomonitoring Systems in Latin America and the Caribbean: Considerations for Potentially Toxic Metals/Metalloids
por: Tamayo-Ortiz, Marcela, et al.
Publicado: (2022)

Idiopathic Noncirrhotic Portal Hypertension: An Appraisal
por: Lee, Hwajeong, et al.
Publicado: (2016)

Choosing New Therapies for Gonorrhoea: We Need to Consider the Impact on the Pan-Neisseria Genome. A Viewpoint
por: Kenyon, Chris, et al.
Publicado: (2021)

Rivaroxaban for the treatment of noncirrhotic splanchnic vein thrombosis: an interventional prospective cohort study
por: Ageno, Walter, et al.
Publicado: (2022)

Policy and Ethical Considerations for Widespread Utilization of Generic Orthopedic Implants
por: Pean, Christian A., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_tbckevacdtu5it5g1ulslk1a65